FABP4 and liver disorder: Although FABP4 correlated significantly with platelet count increase (ρ = −0.48, p = 0.0097) and AST decrease (ρ = −0.45, p=0.0153; Supplementary Fig. S3), those correlations were weaker than the correlation with both composite scores, suggesting that FABP4 levels are associated with the reduction in liver disease.